NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6800
-0.0100 (-1.45%)
At close: Dec 19, 2025
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 61.66 million as of December 19, 2025. Its market cap has increased by 24.26% in one year.
Market Cap
61.66M
Enterprise Value
60.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.68
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 61.66M, an increase of 84.16%. That is a compound annual growth rate of 19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 61.66M | 40.29% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.20B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.18B |
| Extendicare | 2.08B |
| Sienna Senior Living | 2.00B |
| Trulieve Cannabis | 1.97B |
| Cronos Group | 1.55B |
| WELL Health Technologies | 990.54M |